Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease

American Journal of Health-System Pharmacy

Volumn 65, Issue 5, 2008, Pages 414-419

  Lertxundi, Unax ^a   Peral, Javier ^a   Mora, Oihana ^a   Domingo Echaburu, Saioa ^a   Martínez Bengoechea, María Jose ^a   García Moncó, Juan Carlos ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Antiemetics; Antiparkinson agents; Antipsychotic agents; Dopamine antagonists; Hiccup; Nausea; Parkinson disease; Psychotic disorders; Toxicity; Vomiting

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BUTYROPHENONE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; HALOPERIDOL; LEVODOPA; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NIFEDIPINE; OLANZAPINE; ONDANSETRON; PERPHENAZINE; PHENOTHIAZINE; PLACEBO; QUETIAPINE; RISPERIDONE; SELEGILINE; SEROTONIN 3 ANTAGONIST; TRIMETHOBENZAMIDE; VALPROIC ACID; ZIPRASIDONE; ANTIPARKINSON AGENT;

ABSENCE OF SIDE EFFECTS; AGRANULOCYTOSIS; BLOOD BRAIN BARRIER; CLINICAL TRIAL; COMORBIDITY; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EMERGENCY CARE; EVIDENCE BASED MEDICINE; HICCUP; HUMAN; LEUKOPENIA; LOW DRUG DOSE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NAUSEA; NAUSEA AND VOMITING; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; PARKINSONISM; PATHOLOGICAL LAUGHTER; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SOMNOLENCE; STOMACH PARESIS; UNSPECIFIED SIDE EFFECT; VOMITING;

ANTIPARKINSON AGENTS; DOPAMINE ANTAGONISTS; HICCUP; HUMANS; NAUSEA; PARKINSON DISEASE; PSYCHOTIC DISORDERS; VOMITING;

EID: 40349084051     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060624     Document Type: Review

References (75)